Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2020
Tasly proposes sale of Tianshi Marketing stake to Chongqing Pharmaceutical
Tasly and six indirectly controlled partnerships proposed selling a 99.9448% stake in Tianshi Marketing to Chongqing Pharmaceutical for cash. The transaction consideration is to be negotiated by the parties based on an appraisal value.
2020
Tasly announces planned sale of Tianshi Marketing stake
Tasly announced that it and six indirectly controlled partnerships planned to sell a 99.9448% stake in Tianshi Marketing to Chongqing Pharmaceutical (Group), a subsidiary of Chongqing Pharmaceutical Holdings, for approximately RMB 1.489 billion.
2020
Tasly announces proposed sale of pharmaceutical distribution business
Tasly announced that it proposed to sell its pharmaceutical distribution business assets, including a 99.95% stake in Tianjin Tasly Pharmaceutical Marketing Group, for 1.489 billion yuan. Tasly said it would no longer hold a stake in the subsidiary after completion.
2020
Tianshili releases 2019 annual results
Tianshili released its 2019 annual report, reporting revenue of RMB 19 billion, up 5.6%, and net profit of RMB 1.001 billion, down 35.19%.
2019
Tianshi plans to sell Tianshi Marketing stake
Tianshi announced a preliminary framework agreement with Chongqing Pharmaceutical for the proposed sale of its 87.47% stake in Tianshi Marketing, along with shares held by Tianshi Marketing’s other shareholders. The agreement is an initial intention, not a final restructuring plan.